The start of trials is a milestone for Bayer's ambition to develop cell and gene-based therapies for Parkinson's that could replace the dopamine-producing neurons in the midbrain area that are ...

The divestment comes as Bayer is engaged in a push to become a top ten oncology company by 2030, with its ambition driven by prostate cancer treatment Nubeqa (darolutamide), recently tipped to ...

Bayer Leverkusen faced a bitter defeat against Bayern Munich in the second leg of the UEFA Champions League Round of 16, ending their hopes for progression with a comprehensive aggregate score of 0-5.

In the thrilling landscape of European football, few moments resonate more than a handshake that symbolizes unity and ambition. Recently, after Bayern Munich's victory over Bayer Leverkusen in the ...